SEARCH

Search any criteria by typing into the box above or browse from the links below.
Click on drug name or to access monograph.

Vial $2.38

Adrenaline

Editor: Updated Class:

ADMINISTRATION ROUTES:

IV, IM, SC, Nebulised, Endotracheal

ALTERNATIVE NAMES:

Adrenaline mini-jet, EpiPen, Anapen, Epinephrine

ICU INDICATIONS:

  1. Cardiac arrest

  2. Anaphylaxis

  3. Upper airway obstruction

  4. Inotrope / vasopressor

PRESENTATION AND ADMINISTRATION:

IV:

Adrenaline comes in vials containing 1mg in 1 mL (1:1000) and vials containing 1mg in 10 mL (1:10,000). Mini-jets that contain 1mg in 10 mL are also available.

The standard dilution for adrenaline by infusion in the ICU is 10 mg in 100 mL of compatible IV fluid

Compatible with the following IV fluids:

Normal saline, 5% dextrose, Glucose and Sodium Chloride, Hartmann’s

Store at room temperature. Protect from light. Do not refrigerate. Solutions that are discoloured pink or brown should not be used.

IM:

Although IM use is said to be preferred in anaphylaxis and other emergencies, the IV route is generally more appropriate in the ICU setting. Use 1:1000 solution undiluted for administration by the IM route.

Nebulised

Use 1:1000 solution and (if required) make up to a total of 5 mL using Normal saline prior to administration

DOSAGE:

Cardiac arrest:

10 mL of 1:10,000 (i.e 1 mg) IV

OR

3-10 mg of 1:1000 via endotracheal tube if IV access cannot be obtained

Note: in cardiac arrest after cardiac surgery, consideration should be given to immediate sternotomy. If adrenaline is administered in this setting, a standard 1mg dosage is inappropriate due to the risk of rebound hypertension leading to fatal haemorrhage. Give bolus doses of 1 mL of 1:10,000 and uptitrate gently if circulation is not restored

Anaphylaxis:

0.05 mL/kg of 1:10,000 IV with dose titrated to effect followed by IV infusion if required

OR

0.01 mL/kg of 1:1000 IM (avoid administration in the buttocks)

Post-extubation stridor or other upper airway obstruction:

Use the 1:1000 vials up to maximum dose 5 mL and administer via a nebuliser. If giving less than 4 mg, make up to at least 4 mL with 0.9% saline

IV Infusion:

10 mg in 100 mL of 5% dextrose or Normal saline at up to 20 mL/hr titrated to effect

DOSAGE IN RENAL FAILURE AND RENAL REPLACEMENT THERAPY:

No dosage adjustment is required in renal failure or renal replacement therapy

DOSAGE IN PAEDIATRICS:

Cardiac arrest:

0.1 mL/kg of 1:10,000 IV

0.1 mL/kg of 1:1000 via endotracheal tube

Anaphylaxis:

0.05 mL/kg of 1:10,000 IV

OR

0.01 mL/kg of 1:1000 IM

Severe Croup:

Use the 1:1000 vials at a dose of 0.5 mL/kg/dose, maximum dose 5 mL and administer via a nebuliser. Make up to at least 4 mL with 0.9% saline

IV Infusion:

0.3 mg/kg in 50 mL 5% dextrose at 0.5-10 mL/hr (equates to 0.05-1 mcg/kg/min)

CLINICAL PHARMACOLOGY:

Adrenaline is a sympathomimetic drug. It activates an adrenergic receptive mechanism on effector cells and imitates all actions of the sympathetic nervous system except those on the arteries of the face and sweat glands. Adrenaline acts on both alpha and beta receptors

CONTRAINDICATIONS:

There are no absolute contraindications to the use of adrenaline in a life-threatening situation

WARNINGS:

Adrenaline by infusion commonly leads to hyperlactataemia and hyperglycaemia. Adrenaline by infusion may worsen dynamic outflow tract obstruction and paradoxically reduce cardiac output (particularly if used in the setting of hypovolaemia)

PRECAUTIONS:

General:

Some patients may be at greater risk of developing adverse reactions after adrenaline administration. These include hyperthyroid individuals, individuals with cardiovascular disease, hypertension, or diabetes, and the elderly

Laboratory Tests:

Adrenaline infusion commonly leads to increased lactate. It may be necessary to measure lactate levels if there are clinical concerns.

Drug/Laboratory Test Interactions: None reported

IMPORTANT DRUG INTERACTIONS IN ICU:

The effects of adrenaline may be potentiated by tricyclic antidepressants and monoamine oxidase inhibitors.

ADVERSE REACTIONS:

Body as a Whole:

Apprehension, nervousness, anxiety and sweating.

Cardiovascular System:

Palpitations, tachycardia, pallor.

Respiratory System:

Hyperventilation, pulmonary oedema

Digestive System:

Nausea and vomiting,

Nervous System:

Headache, tremor, dizziness, weakness, cerebrovascular haemorrhage